gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
Published 12 years ago • 1.2K plays • Length 7:41Download video MP4
Download video MP3
Similar videos
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
4:30
gracecast-117_lung-cancer_asco 2012 lc highlights: dr. neal on molecular targets in squamous nsclc
-
42:48
immunotherapy for lung cancer
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
5:24
gracecast - lcvl - can immunotherapy help frail patients with advanced nsclc
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
9:18
gracecast - treatment options for metastatic nsclc
-
8:03
studies in anti-pd-l1 monotherapy for nsclc - lung cancer onctalk 2022
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc
-
9:29
gracecast - lcvl - could pre-operative immunotherapy improve outcomes in early stage nsclc
-
6:52
combination chemotherapy and immunotherapy for patients with high pd-l1 nsclc - 2022 program: lcvl
-
9:26
gracecast - lcvl - which patients with advanced nsclc are good candidates for first line immunothera
-
10:57
gracecast-033_lung-cancer_individualizing treatment for nsclc
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
1:46
immunotherapy for patients with resectable nsclc & driver mutation-targeted therapies in lung cancer
-
9:19
gracecast-004_lung-cancer_antiangiogenesis in first line nsclc
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts